Navigation Links
Ardea Biosciences, Inc. Reports Third Quarter 2007 Operating and Financial Results
Date:11/14/2007

rry D. Quart, President and CEO. "We made significant progress in advancing our business and in the development of our pipeline, achieving several important milestones." These include:

-- Completion of Phase 1 single-ascending-dose, multiple-ascending-dose,

food-effect, and drug-interaction clinical studies of RDEA806, our lead

non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV, in

August of 2007;

-- Presentation of four posters describing the favorable results of

preclinical and Phase 1 clinical trials with RDEA806 during the 47th

Annual Interscience Conference on Antimicrobial Agents and Chemotherapy

(ICAAC);

-- Completion, submission and FDA approval of our investigational new drug

application (IND) for our lead mitogen-activated ERK kinase (MEK)

inhibitor, RDEA119, allowing us to proceed to Phase 1 clinical trials

in advanced cancer patients; and

-- Presentation of RDEA119 preclinical data, showing favorable properties,

including oral dosing, excellent selectivity and low central nervous

system (CNS) penetration, at the American Association of Cancer

Research (AACR), National Cancer Institute (NCI) and European

Organization for Research and Treatment of Cancer (EORTC) International

Conference on Molecular Targets and Cancer Therapeutics.

"We are well positioned for continued progress and success with our development programs in viral diseases, cancer and inflammatory diseases and are working to achieve several milestones in the next few months," added Dr. Quart. These include:

-- Initiation of a Phase 2a proof-of-concept trial with our lead NNRTI,

RDEA806;

-- Assessing a next-generation NNRTI from our follow-on program in a

first-in-human micro-dosing study;

-- Initiation of a Phase 1 advanced cancer clinical study of our lead MEK

inhibitor, RDEA119;'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
2. Ardea Biosciences Announces Changes to Research Management
3. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
4. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
5. Pressure BioSciences, Inc. Issued First Patent in Canada
6. Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320
7. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
8. Pressure BioSciences, Inc. Provides Corporate Update
9. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
10. QMed, Inc. Reports July Medicare SNP Enrollments
11. Phlo Affiliate Reports Expanded Coverage to Oregon Border
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... Graphite Metallizing Corporation, the manufacturer ... the appointment of Dennis Rawle as European Director of Sales. Rawle has over ... was General Manager and Technical Sales Manager for pump products at Exalto UK. ...
(Date:8/4/2015)... PORTLAND, Oregon , August 4, 2015 /PRNewswire/ ... published by Allied Market Research, titled, "World Cardiac ... global cardiac biomarker market would generate the revenue ... of 18.9% from 2015 to 2020. Cardiac Troponins ... throughout the forecast period due to high sensitivity ...
(Date:8/4/2015)... 4, 2015 Trigemina, Inc., a biopharmaceutical company ... delivered, analgesic drug products, announced today that the company ... of chief medical officer. Dr. Kori brings over 30 ... which has been focused in the neuroscience and headache ... Kori to our clinical team given his vast experience ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... point-of-care (POC) diagnostic tests – today announced that Robert A. Gregg, PhD, has ... has more than 30 years of relevant experience and remarkable achievements in the ...
Breaking Biology Technology:Dennis Rawle Joins Graphite Metallizing Corporation 2Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 2Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 3Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 4Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 5Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 2Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 3RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 2RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 3
... SUNNYVALE, Calif., June 24 Cepheid (Nasdaq: CPHD ... Universal Antenatal Screening for Group B Streptococcus, published in ... Medicine concluded that rapid, PCR-based testing at the time of ... streptococcal (GBS) screening over the normal antepartum testing done at ...
... neuropathy, and other conditions caused by a loss of myelin ... adequate treatments do not yet exist. That,s in large part ... issue of the journal Biomaterials , a UCF team ... motor nerves that are insulated and organized the same way ...
... 23 Environmental Tectonics Corporation (OTC Bulletin Board: ETCC) ... Division will be exhibiting at the upcoming Undersea and ... non-profit organization and is the primary source of scientific ... , The 2009 Annual UHMS meeting will be ...
Cached Biology Technology:New England Journal of Medicine Study Highlights Need for Rapid, PCR-based Group B Streptococcus (GBS) Testing at Time of Admission for Labor and Delivery 2New England Journal of Medicine Study Highlights Need for Rapid, PCR-based Group B Streptococcus (GBS) Testing at Time of Admission for Labor and Delivery 3New England Journal of Medicine Study Highlights Need for Rapid, PCR-based Group B Streptococcus (GBS) Testing at Time of Admission for Labor and Delivery 4UCF team's advanced nerve cell system could help cure diabetic neuropathy, related diseases 2UCF team's advanced nerve cell system could help cure diabetic neuropathy, related diseases 3UCF team's advanced nerve cell system could help cure diabetic neuropathy, related diseases 4Environmental Tectonics Corporation's BioMedical Division to Exhibit at Undersea and Hyperbaric Medical Society Meeting 2Environmental Tectonics Corporation's BioMedical Division to Exhibit at Undersea and Hyperbaric Medical Society Meeting 3Environmental Tectonics Corporation's BioMedical Division to Exhibit at Undersea and Hyperbaric Medical Society Meeting 4
(Date:8/4/2015)... Research and ... addition of the "Digital Forensics Market ... (Computer Forensics, Network Forensics, Mobile Device Forensics, ... and Region - Global Forecast to 2020" ... By Component (Hardware, Software, and Service), Sub-Segment ...
(Date:8/4/2015)... 2015  AMRI (NASDAQ: AMRI ) today reported financial and ... Highlights: , Second quarter contract revenue of ... , Adjusted contract margins of 26 % ... a $0.05 decrease in EPS from royalties in the current quarter ... "We are very pleased to present another strong financial ...
(Date:8/3/2015)... 2015 Synaptics, Inc. (Nasdaq: SYNA ), ... that members of the executive management team will present ... Technology Leadership Forum on Tuesday, August 11, 2015 at ... at the Sonnenalp Resort in Vail, CO. ... forward-looking information. An audio webcast of the event will ...
Breaking Biology News(10 mins):Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24
... , Invasions of voracious predatory crabs due to global ... according to newly published findings. "King crabs ... economically significant commercial fisheries," said Dr Sven Thatje, an ... Ocean and Earth Science (SOES), which is based at ...
... A team of scientists has, for the first time, completely ... formation of ground-level ozone in urban areas. The team,s results ... urban areas during episodes of poor air quality (smoggy days) ... level ozone poses significant health hazards to people, animals and ...
... One of the many advantages of maintaining a normal body ... healthy heart. Fat tissue is increasingly seen as more than ... organ that normally produces high levels of a cardioprotective hormone ... has long been a mystery, and now a team led ...
Cached Biology News:King crab distributions limited by temperature in the Southern Ocean 2Study improves accuracy of models for predicting ozone levels in urban areas 2Study improves accuracy of models for predicting ozone levels in urban areas 3Study improves accuracy of models for predicting ozone levels in urban areas 4Study finds fat hormone's long-sought link to heart protection 2
... Stabilizer has been developed specifically for ... proteins on microwell plates/strips. Coating ... of the antibody or protein antigen ... Product is filtered at 0.2 ...
... Novagen's HT96 Isothermal Block is an anodized ... HT96 plates and to provide efficient thermal ... This new design of the HT96 Isothermal ... an enhanced product design allowing for compatibility ...
Umbilical cord blood neutrophils, For immunohistochemistry (IHC)...
...
Biology Products: